By acting on the bromodomain-containing protein 4 (BRD4) signaling pathway through the small-molecule inhibitor JQ1, SEs can regulate the downregulation of Myc protein and mRNA levels, thereby preventing the proliferation, invasion, and migration of HCC [96]. The gene discussed is BRD4; the disease is hepatocellular carcinoma.